PRIMECAP MANAGEMENT CO/CA/ 13D and 13G filings for Calithera Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 4:02 pm Purchase | 2022-12-31 | 13G | Calithera Biosciences, Inc. CALA | PRIMECAP MANAGEMENT CO/CA/ | 401,080 8.240% | 201,117 (+100.58%) | Filing |
| 2023-02-09 4:01 pm Sale | 2023-01-31 | 13G | Calithera Biosciences, Inc. CALA | PRIMECAP MANAGEMENT CO/CA/ | 199,963 4.110% | -206,317 (-50.78%) | Filing |
| 2022-12-08 11:49 am Purchase | 2022-11-30 | 13G | Calithera Biosciences, Inc. CALA | PRIMECAP MANAGEMENT CO/CA/ | 406,280 8.350% | 406,280 (New Position) | Filing |